The Legacy of Fortune
Founded in 1954, Fortune Pharmacal has been a steadfast companion to the citizens of Hong Kong, navigating through the ebb and flow of time together. Over the past half-century, we are remained dedicated to the research, development and production of over-the-counter (OTC) pharmaceuticals. We have been actively expanding manufacturing facilities, optimizing manufacturing systems, innovating pharmaceutical formulas, all with the unwavering aim of safeguarding public health.As Fortune Pharmacal is “always going one step further”, we are committed to passing the legacy of fortune to our future generation. As an industry pioneer, we have taken the lead in focusing on and implementing environmental, social and corporate governance (ESG) initiatives. Our mission extends beyond serving Hong Kong people, reaching out to the globally community in our pursuit of sustainable development goals.
Hong Kong Market Sales Leader Promoting Healthier, Better Lives
Insisting on local manufacturing and integrating many years of technology and experience, Fortune Pharmacal’s cold and flu series, Coltalin, has firmly positioned itself as the leader in cold and flu medicine sales in Hong Kong since 1998¹. In addition to best-selling Coltalin adult tablets and children's chewable tablets, we have also developed a diversified range of over-the-counter medicines to meet the needs of different customers. As Fortune Pharmacal is “always going one step further”, we are committed to developing health care solutions for infants up to the elderly, as well as medicines for patients with chronical illnesses, with objective to cover all age groups for their enhancement of health and life quality.
Establishment of Yuen Long Headquarters Upgrading Quality and Manufacturing Capacity
Fortune Pharmacal’s new headquarters in Yuen Long covers an area of over 47,000 square feet. The new plant boasts a manufacturing capacity four times that of the previous one, achieving a significant increase in overall productivity to facilitate further business diversification. As Fortune Pharmacal is “always going one step further”, the whole-new space of development not only enhances the optimization of existing medical and healthcare products, but also allows the company to actively invest resources in research and development of over-the-counter (OTC) medications, prescription medicines and other dosage forms, providing a solid foundation for the company’s sustainable development, and spreading “fortune” to everywhere in the world through expansion of overseas markets.
-
1954
Fortune Pharmacal founded by Mr. LAI Yung Kwoon
-
1968
Introduced manufacturing equipment from Europe and established semi-automatic production line
-
1985
Medical products reached U.S. FDA standard and exported to U.S. and Canada
-
1990
Established Guangzhou branch to expand China market
-
2005
Obtained WHO-standard GMP certification from the Department of Health, HKSAR
-
2012
Promote values of “Always Going One Step Further” and take up corporate social responsibility through actions for environmental and community wellness
-
2014
Established FP Healthcare for introduction of diversified overseas products and further expansion of medical and healthcare markets
-
2015
Obtained top-strict GMP certification for reaching PIC/S standard
-
2022
Commenced operation of new plant in Yuen Long, introduced full-automated production lines and realized 4x increase in production capacity
Fortune Pharmacal strives to achieve the goal of brand excellence. We are resolute in local manufacturing, constant optimization of product quality and efficacy, and advocating for a healthier society. We pride ourselves in our ability to “always go one step further”.
Fortune Pharmacal's concept of health is not limited to just physical and mental health, but also broader environmental and social health.
Fortune Pharmacal adheres to its corporate responsibilities and creates a win-win environment with every relevant stakeholder, including customers, partners, employees, and shareholders, striving to incorporate sustainable development into the company's mission and being committed to having a positive impact on both society and the environment.
Fortune Pharmacal takes important measures to advocate environmental responsibility through such initiatives as formulating carbon emission reduction controls and improving the environmental awareness of employees, the industry, and the general public. The company’s objective is to involve everyone to create a future of good fortune.
Fortune Pharmacal adheres to its corporate responsibilities and creates a win-win environment with every relevant stakeholder, including customers, partners, employees, and shareholders, striving to incorporate sustainable development into the company's mission and being committed to having a positive impact on both society and the environment.
Fortune Pharmacal takes important measures to advocate environmental responsibility through such initiatives as formulating carbon emission reduction controls and improving the environmental awareness of employees, the industry, and the general public. The company’s objective is to involve everyone to create a future of good fortune.
Learn more
Fortune Tablets are 100% Made in Hong Kong
Fortune Pharmacal has always attached great importance to the quality and efficacy of medication products. Our manufacturing plants are designed with high-standard closed systems, and we implement real-time monitoring and control to minimize the risk of cross-contamination during production.
Each Fortune tablet undergoes the highest standard of quality and safety assessment from production to sale. Our production process adheres to the standards set by the Pharmaceutical Inspection Convention (PIC/S), which is currently the most stringent standard of Good Manufacturing Practice (GMP). Furthermore, all our medication products have been approved by the Hong Kong Department of Health and the National Medial Products Administration. Our exported products comply with the international drug registration standards and have been approved by local drug regulatory authorities.
In addition, Fortune Pharmacal is committed to “100% Made in Hong Kong”, maintaining local production to effectively control carbon emissions caused by long-distance transportation and logistics, thereby contributing to local sustainable development.
Industry 4.0 Smart Manufacturing
The Yuen Long manufacturing plant of Fortune Pharmacal is equipped with the most advanced Manufacturing Executive System (MES). Through electronic records, our staff can integrate processes and operational data to adjust production machinery and step settings in real time, ensuring consistent product quality.
The plant has also introduced an Environmental Monitoring System (EMS), which monitors and records the parameters of production environment around the clock. The system automatically adjusts or issues alarms to further enhance the stability of production.
We incorporate artificial intelligence to the frontline operations of the plant and assist in planning the company’s future production capacity. In the long run, we aim to develop an operational model of “quick to respond, precise in production and reduce waste”, enhancing our competitive edge and aligning with our mission of sustainable development.
The plant has also introduced an Environmental Monitoring System (EMS), which monitors and records the parameters of production environment around the clock. The system automatically adjusts or issues alarms to further enhance the stability of production.
We incorporate artificial intelligence to the frontline operations of the plant and assist in planning the company’s future production capacity. In the long run, we aim to develop an operational model of “quick to respond, precise in production and reduce waste”, enhancing our competitive edge and aligning with our mission of sustainable development.
Our Commitment to the Public
Assume corporate responsibility, creating a win-win environment with every stakeholder, including customers, partners and employees
Our Commitment to Society
Recognize the various impacts a corporate brings to society, optimizing company policies, promoting volunteer activities and charitable donations to give back to society, seeking to co-create and enjoy good fortune
Our Commitment to the Environment
Champion sustainable development as the corporate’s mission trough actively utilizing renewable energy sources, introducing automated warehouses, etc., all in an effort to reduce carbon emissions and “go one step further” for our future
1. Fortune Pharmacal's cold and flu series, Coltalin, has been the sales leader in Hong Kong since 1998. [Data source: IQVA Pharma Inc. Database]
